2O9 vs DXRX: Side-by-Side Comparison
Compare RENALYTIX PLC LS-0025 (2O9) and Diaceutics PLC (DXRX) side by side: market cap EUR 8.74M vs GBX 12.35B. Financials, growth and model signals on Bullrun.
| Metric | 2O9 | DXRX |
|---|---|---|
| Company | RENALYTIX PLC LS-0025 | Diaceutics PLC |
| Country / Exchange | United Kingdom · F | United Kingdom · LSE |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Health Information Services |
| Market cap | EUR 8.74M | GBX 12.35B |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | — | GBP 32.16M |
| Revenue growth YoY | — | +35.7% |
| Net income | — | GBP -1.70M |
| Gross margin | — | 87.9% |
| Diluted EPS | — | — |